|
Volumn 49, Issue SUPL. S1, 2002, Pages 69-73
|
Neonatal candidosis: Clinical picture, management controversies and consensus, and new therapeutic options
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
AMPHOTERICIN B LIPID COMPLEX;
ANTIBIOTIC AGENT;
FLUCONAZOLE;
FLUCYTOSINE;
TRIAZOLE DERIVATIVE;
ANTIFUNGAL ACTIVITY;
ARTICLE;
CANDIDA ALBICANS;
CANDIDA PARAPSILOSIS;
CANDIDA TROPICALIS;
CANDIDIASIS;
CHILL;
CLINICAL FEATURE;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG CHOICE;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MEGADOSE;
DRUG SAFETY;
ENCAPSULATION;
FEVER;
HUMAN;
HYPOKALEMIA;
IMMUNE DEFICIENCY;
INFANT;
INFECTION RISK;
LOW BIRTH WEIGHT;
NAUSEA AND VOMITING;
NEPHROTOXICITY;
NEWBORN DISEASE;
NEWBORN INTENSIVE CARE;
NEWBORN MORBIDITY;
NEWBORN MORTALITY;
NEWBORN SEPSIS;
PREMATURITY;
SYSTEMIC MYCOSIS;
TREATMENT PLANNING;
|
EID: 0036181370
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: 10.1093/jac/49.suppl_1.69 Document Type: Article |
Times cited : (49)
|
References (22)
|